{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:45:03Z","timestamp":1793861103592,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32430059"],"award-info":[{"award-number":["32430059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471434"],"award-info":[{"award-number":["32471434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271442"],"award-info":[{"award-number":["32271442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64200-9","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:24:07Z","timestamp":1760520247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Muscle-specific gene editing therapy via mammalian fusogen-directed virus-like particles"],"prefix":"10.1038","volume":"16","author":[{"given":"Shi-Kun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Tong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Hong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-0950","authenticated-orcid":false,"given":"Xian-Zhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-5711","authenticated-orcid":false,"given":"Cong-Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9957-9208","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"64200_CR1","doi-asserted-by":"publisher","first-page":"e1462","DOI":"10.1002\/wsbm.1462","volume":"12","author":"K Mukund","year":"2020","unstructured":"Mukund, K. & Subramaniam, S. Skeletal muscle: a review of molecular structure and function, in health and disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 12, e1462 (2020).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"64200_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1113\/jphysiol.2003.045328","volume":"551","author":"JC Bruusgaard","year":"2003","unstructured":"Bruusgaard, J. C., Liest\u00f8l, K., Ekmark, M., Kollstad, K. & Gundersen, K. Number and spatial distribution of nuclei in the muscle fibres of normal mice studied in vivo. J. Physiol. 551, 467\u2013478 (2003).","journal-title":"J. Physiol."},{"key":"64200_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri, E. & Muntoni, F. Muscular dystrophies. Lancet 381, 845\u2013860 (2013).","journal-title":"Lancet"},{"key":"64200_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S., Mercuri, E. & Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis. Prim. 7, 13 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"64200_CR5","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri, E., B\u00f6nnemann, C. G. & Muntoni, F. Muscular dystrophies. Lancet 394, 2025\u20132038 (2019).","journal-title":"Lancet"},{"key":"64200_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/hum.2018.243","volume":"30","author":"NB Wasala","year":"2019","unstructured":"Wasala, N. B., Hakim, C. H., Chen, S. J., Yang, N. N. & Duan, D. Questions answered and unanswered by the first CRISPR editing study in a canine model of Duchenne muscular dystrophy. Hum. Gene Ther. 30, 535\u2013543 (2019).","journal-title":"Hum. Gene Ther."},{"key":"64200_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"64200_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M. et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407\u2013411 (2016).","journal-title":"Science"},{"key":"64200_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40788-8","volume":"14","author":"D Strebinger","year":"2023","unstructured":"Strebinger, D. et al. Cell type-specific delivery by modular envelope design. Nat. Commun. 14, 5141 (2023).","journal-title":"Nat. Commun."},{"key":"64200_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","volume":"10","author":"ND Mazarakis","year":"2001","unstructured":"Mazarakis, N. D. et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109\u20132121 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"64200_CR11","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","volume":"195","author":"Q Zhou","year":"2015","unstructured":"Zhou, Q. et al. Exclusive transduction of human CD4+ T cells upon systemic delivery of CD4-targeted lentiviral vectors. J. Immunol. 195, 2493\u20132501 (2015).","journal-title":"J. Immunol."},{"key":"64200_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822\u2013826 (2013).","journal-title":"Nat. Biotechnol."},{"key":"64200_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"64200_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e216 (2022).","journal-title":"Cell"},{"key":"64200_CR15","doi-asserted-by":"publisher","first-page":"109207","DOI":"10.1016\/j.celrep.2021.109207","volume":"35","author":"JR Hamilton","year":"2021","unstructured":"Hamilton, J. R. et al. Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 35, 109207 (2021).","journal-title":"Cell Rep."},{"key":"64200_CR16","first-page":"151","volume":"27","author":"LA Campbell","year":"2019","unstructured":"Campbell, L. A. et al. Gesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex for inactivating the HIV provirus. Cell Rep. 27, 151\u2013163 (2019).","journal-title":"Cell Rep."},{"key":"64200_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12076","volume":"10","author":"X Yao","year":"2021","unstructured":"Yao, X. et al. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing. J. Extracell. Vesicles 10, e12076 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"64200_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee, P. et al. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat. Commun. 11, 1334 (2020).","journal-title":"Nat. Commun."},{"key":"64200_CR19","unstructured":"Editas Medicine. Editas Medicine announces positive initial clinical data from ongoing phase 1\/2 BRILLIANCE clinical trial of EDIT-101 for LCA10. Press release Available at: https:\/\/ir.editasmedicine.com\/news-releases\/news-release-details\/editas-medicine-announces-positive-initial-clinical-data-ongoing (2021)."},{"key":"64200_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D., Maitland, M. L. & Lebwohl, D. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 1722\u20131723 (2021).","journal-title":"N. Engl. J. Med."},{"key":"64200_CR21","doi-asserted-by":"crossref","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. 42, 1684\u20131692 (2024).","DOI":"10.1038\/s41587-023-02085-z"},{"key":"64200_CR22","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1073\/pnas.1101874108","volume":"108","author":"SJ Kaczmarczyk","year":"2011","unstructured":"Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H. & Chatterjee, D. K. Protein delivery using engineered virus-like particles. Proc. Natl. Acad. Sci. USA 108, 16998\u201317003 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64200_CR23","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","volume":"186","author":"SM Hindi","year":"2023","unstructured":"Hindi, S. M. et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell 186, 2062\u20132077.e2017 (2023).","journal-title":"Cell"},{"key":"64200_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.tcb.2019.09.002","volume":"29","author":"MJ Petrany","year":"2019","unstructured":"Petrany, M. J. & Millay, D. P. Cell fusion: merging membranes and making muscle. Trends Cell Biol. 29, 964\u2013973 (2019).","journal-title":"Trends Cell Biol."},{"key":"64200_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1126\/science.aam9361","volume":"356","author":"P Bi","year":"2017","unstructured":"Bi, P. et al. Control of muscle formation by the fusogenic micropeptide myomixer. Science 356, 323\u2013327 (2017).","journal-title":"Science"},{"key":"64200_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature12343","volume":"499","author":"DP Millay","year":"2013","unstructured":"Millay, D. P. et al. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature 499, 301\u2013305 (2013).","journal-title":"Nature"},{"key":"64200_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15665","volume":"8","author":"ME Quinn","year":"2017","unstructured":"Quinn, M. E. et al. Myomerger induces fusion of non-fusogenic cells and is required for skeletal muscle development. Nat. Commun. 8, 15665 (2017).","journal-title":"Nat. Commun."},{"key":"64200_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15664","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. The microprotein minion controls cell fusion and muscle formation. Nat. Commun. 8, 15664 (2017).","journal-title":"Nat. Commun."},{"key":"64200_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.stem.2018.06.010","volume":"23","author":"SS Chan","year":"2018","unstructured":"Chan, S. S. et al. Skeletal muscle stem cells from PSC-derived teratomas have functional regenerative capacity. Cell Stem Cell 23, 74\u201385.e76 (2018).","journal-title":"Cell Stem Cell"},{"key":"64200_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-016-0106-6","volume":"6","author":"CC Maesner","year":"2016","unstructured":"Maesner, C. C., Almada, A. E. & Wagers, A. J. Established cell surface markers efficiently isolate highly overlapping populations of skeletal muscle satellite cells by fluorescence-activated cell sorting. Skelet. Muscle 6, 35 (2016).","journal-title":"Skelet. Muscle"},{"key":"64200_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10654-021-00819-4","volume":"37","author":"L Wahlgren","year":"2022","unstructured":"Wahlgren, L., Kroksmark, A. K., Tulinius, M. & Sofou, K. One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure. Eur. J. Epidemiol. 37, 147\u2013156 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"64200_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig, M. et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509\u2013517 (1987).","journal-title":"Cell"},{"key":"64200_CR33","first-page":"9","volume":"34","author":"A Taglia","year":"2015","unstructured":"Taglia, A. et al. Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene. Acta Myol. 34, 9\u201313 (2015).","journal-title":"Acta Myol."},{"key":"64200_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.76","volume":"4","author":"Y Echigoya","year":"2015","unstructured":"Echigoya, Y. et al. Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice. Mol. Ther. Nucleic Acids 4, e225 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"64200_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14454","volume":"8","author":"NE Bengtsson","year":"2017","unstructured":"Bengtsson, N. E. et al. Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat. Commun. 8, 14454 (2017).","journal-title":"Nat. Commun."},{"key":"64200_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19230-w","volume":"11","author":"J Weinmann","year":"2020","unstructured":"Weinmann, J. et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat. Commun. 11, 5432 (2020).","journal-title":"Nat. Commun."},{"key":"64200_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7150\/thno.47007","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Shen, J., Li, D. & Cheng, Y. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing. Theranostics 11, 614\u2013648 (2021).","journal-title":"Theranostics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64200-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64200-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64200-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:24:11Z","timestamp":1760520251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64200-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64200"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64200-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4869043\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9145"}}